348 related articles for article (PubMed ID: 9635385)
1. Nodular scleritis: case report involving immunosuppressive therapy.
Niemann KK; Bartlett JD; Heck LW; McCollum CJ
J Am Optom Assoc; 1997 Dec; 68(12):782-7. PubMed ID: 9635385
[TBL] [Abstract][Full Text] [Related]
2. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
3. Scleritis therapy.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
[TBL] [Abstract][Full Text] [Related]
4. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey.
Erkanli L; Akova YA; Guney-Tefekli E; Tugal-Tutkun I
Cornea; 2010 Jan; 29(1):26-33. PubMed ID: 19907295
[TBL] [Abstract][Full Text] [Related]
5. Topical cyclosporine A as a steroid-sparing agent in steroid-dependent idiopathic ocular myositis with scleritis: a case report and review of the literature.
Gumus K; Mirza GE; Cavanagh HD; Karakucuk S
Eye Contact Lens; 2009 Sep; 35(5):275-8. PubMed ID: 19687744
[TBL] [Abstract][Full Text] [Related]
6. [Episcleritis and scleritis. An overview of modern diagnostic and therapeutic concepts].
Denk PO; Thiel HJ; Zierhut M
Klin Monbl Augenheilkd; 1997 Sep; 211(3):140-50. PubMed ID: 9445894
[TBL] [Abstract][Full Text] [Related]
7. Nodular scleritis and panuveitis with erythema elevatum diutinum.
Mitamura Y; Fujiwara O; Miyanishi K; Sato H; Saga K; Ohtsuka K
Am J Ophthalmol; 2004 Feb; 137(2):368-70. PubMed ID: 14962440
[TBL] [Abstract][Full Text] [Related]
8. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients.
McCluskey PJ; Watson PG; Lightman S; Haybittle J; Restori M; Branley M
Ophthalmology; 1999 Dec; 106(12):2380-6. PubMed ID: 10599675
[TBL] [Abstract][Full Text] [Related]
9. Therapy insight: scleritis and its relationship to systemic autoimmune disease.
Smith JR; Mackensen F; Rosenbaum JT
Nat Clin Pract Rheumatol; 2007 Apr; 3(4):219-26. PubMed ID: 17396107
[TBL] [Abstract][Full Text] [Related]
10. Smoking delays the response to treatment in episcleritis and scleritis.
Boonman ZF; de Keizer RJ; Watson PG
Eye (Lond); 2005 Sep; 19(9):949-55. PubMed ID: 15543188
[TBL] [Abstract][Full Text] [Related]
11. Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis.
Roufas A; Jalaludin B; Gaskin C; McCluskey P
Br J Ophthalmol; 2010 Jun; 94(6):743-7. PubMed ID: 20447959
[TBL] [Abstract][Full Text] [Related]
12. The tyranny of the anecdote: Waldenstrom's macroglobulinemia and scleritis.
Rosenbaum JT; Becker MD
Ocul Immunol Inflamm; 2000 Jun; 8(2):111-3. PubMed ID: 10980683
[TBL] [Abstract][Full Text] [Related]
13. Diffuse granulomatous necrotizing scleritis.
Pecorella I; La Cava M; Mannino G; Pinca M; Pezzi PP
Acta Ophthalmol Scand; 2006 Apr; 84(2):263-5. PubMed ID: 16637849
[TBL] [Abstract][Full Text] [Related]
14. Severity of episcleritis and systemic disease association.
Akpek EK; Uy HS; Christen W; Gurdal C; Foster CS
Ophthalmology; 1999 Apr; 106(4):729-31. PubMed ID: 10201593
[TBL] [Abstract][Full Text] [Related]
15. [Scleritis: when might a systemic disease be involved?].
Gabison E; Hoang-Xuan T
J Fr Ophtalmol; 2010 Oct; 33(8):593-8. PubMed ID: 20728244
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas scleritis resistant to fourth-generation fluoroquinolones in a patient without prior trauma or surgery.
Meyer JJ; Espandar L; Marx DP; Vitale A; Moshirfar M
Ocul Immunol Inflamm; 2008; 16(3):127-9. PubMed ID: 18569805
[TBL] [Abstract][Full Text] [Related]
17. Recurrent nodular scleritis preceding an adult TINU syndrome.
Daniel E; Gangaputra S; Kempen JH; Jabs DA
Ocul Immunol Inflamm; 2006 Aug; 14(4):239-40. PubMed ID: 16911986
[TBL] [Abstract][Full Text] [Related]
18. Myositis and scleritis associated with Behcet's disease: an atypical presentation.
Dursun D; Akova Y; Yücel E
Ocul Immunol Inflamm; 2004 Dec; 12(4):329-32. PubMed ID: 15621873
[TBL] [Abstract][Full Text] [Related]
19. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and presentation of posterior scleritis: a report of 31 cases.
Gonzalez-Gonzalez LA; Molina-Prat N; Doctor P; Tauber J; Sainz de la Maza M; Foster CS
Ocul Immunol Inflamm; 2014 Jun; 22(3):203-7. PubMed ID: 24131324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
